Cerebral Oximetry in Newborns - Comparing INVOS 5100 and FORE-SIGHT Cerebral Oximeters
Status
Completed
Conditions
Near Infrared Spectroscopy
Details and patient eligibility
About
Regional tissue oxygenation (rStO2) can be monitored by near infrared spectroscopy. The commercial devices FORE-SIGHT (CASMED) and INVOS (COVIDIEN) will be used simultaneously to test for their relative sensitivity for low oxygen levels just after birth on term infants born by elective cesarean section. Reproducibility will be examined by replacements of the sensors six times the next day when the infant is stable and quiet. Neonatal sensors will be used.
Enrollment
12 estimated patients
Sex
All
Ages
Under 2 minutes old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
- Term infants (age more than 37 weeks of gestation)
- Elective cesarean section after an uncomplicated pregnancy
Exclusion criteria
- Thick hair that makes good measurements difficult/impossible
- Obvious malformations or syndrome
- Complications in relation to the cesarean section
- Depression after birth (APGAR < 8 after 1 minute)
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems